| Literature DB >> 31259073 |
David Nguyen1,2,3, Virginie Uhlmann4,5, Arielle L Planchette1,3, Paul J Marchand3, Dimitri Van De Ville2,6, Theo Lasser3, Aleksandra Radenovic1.
Abstract
Alzheimer's disease (AD) is characterized by amyloidosis of brain tissues. This phenomenon is studied with genetically-modified mouse models. We propose a method to quantify amyloidosis in whole 5xFAD mouse brains, a model of AD. We use optical projection tomography (OPT) and a random forest voxel classifier to segment and measure amyloid plaques. We validate our method in a preliminary cross-sectional study, where we measure 6136 ± 1637, 8477 ± 3438, and 17267 ± 4241 plaques (AVG ± SD) at 11, 17, and 31 weeks. Overall, this method can be used in the evaluation of new treatments against AD.Entities:
Year: 2019 PMID: 31259073 PMCID: PMC6583328 DOI: 10.1364/BOE.10.003041
Source DB: PubMed Journal: Biomed Opt Express ISSN: 2156-7085 Impact factor: 3.732